3 documents found, page 1 of 1
Asdas responses in patients with axial spondyloarthritis starting bdmards: resu...
Santos, M. E.; Ramiro, S.; Van der Heijde, D.; Landewé, R.; Santos, F. Pimentel; Machado, A. R. Cruz; Ferreira, C.; Gomes, C.; Soares, C. DantasASAS and EULAR recommend the use of an improvement ≥1.1 in ASDAS at 12 weeks to determine the continuation of a bDMARD. However, it is debated whether improvements can occur and whether patients’ characteristics influence (time to) response.
Predictors of myositis in mixed connective tissue disease: a multicentre retros...
Melo, A. T.; António, M. Silvério; Martinho, J. Martins; Guimarães, F.; Dourado, E.; Oliveira, D.; Lopes, J.; Saraiva, A.; Gago, A.; Correia, M.Objectives: We aimed to identify clinical and serological predictors of myositis in mixed connective tissue disease (MCTD). Methods: We performed a nationwide, retrospective, multicentre study including adult-onset MCTD patients fulfilling at least one of the following diagnostic criteria: Sharp’s, Kasukawa, Alarcón-Segovia, or Kahn’s. Univariable analysis was performed using Chi-square, Fisher exact, Student’s...
POS0815- Differences in giant cell arteritis manifestations according to the ul...
Martinho, J.; Sousa Bandeira, M. J.; Barreira, S. C.; Dourado, E.; Cruz-Machado, A. R.; Teixeira, V.; Macieira, C.; Khmelinskii, N.; Fonseca, J. E.Giant cell arteritis (GCA) is the most common form of primary systemic vasculitis in patients aged >50 years. It predominantly affects the cranial arteries; however, extra-cranial disease involving the aorta and its major branches, known as large-vessel GCA (LV-GCA), can be present in 20-80% of cases, depending on the imaging modality used for screening the disease.